---
schema_version: "secwatch.filing_event.v1"
accession: "0001564590-22-022999"
form_type: "8-K"
ticker: "TECX"
cik: "0001681087"
company_name: "Tectonic Therapeutic, Inc."
filed_at: "2022-06-10T23:59:59+00:00"
generated_at: "2026-06-25T02:48:29.641484+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# AVROBIO stockholders approve plan amendment increasing authorized shares to 13,486,099

## Summary
- Elected Gail Farfel, Christopher Paige, and Philip Vickers as Class I directors with over 20M votes each.
- Ratified Ernst & Young as independent auditor for FY2022 with 33.8M votes for, 57,906 against.
- Approved amendment to 2018 Stock Plan adding 13,486,099 shares and imposing 12-month minimum vesting (excluding 5% pool).
- Shares forfeited after March 2, 2022 will be added back to the plan reserve under the amended terms.

## SEC filing metadata
- accession: 0001564590-22-022999
- form_type: 8-K
- ticker: TECX
- cik: 0001681087
- company_name: Tectonic Therapeutic, Inc.
- filed_at: 2022-06-10T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1681087/000156459022022999/0001564590-22-022999-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1681087/000156459022022999/avro-8k_20220608.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001564590-22-022999
- JSON: https://secwatch.observer/filing/0001564590-22-022999.json
- Plain text: https://secwatch.observer/filing/0001564590-22-022999.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.